Lexent Bio
formerly LexentBioAcquiredSan Francisco, United States · Founded 2009 · $10.2M raised
- Headquarters
- San Francisco, California
- Employees
- 11–50
- Founded
- 2009
- Business Model
- B2B
- Website
- lexentbio.com
- Total Funding
- $10.2M
- Rounds
- 1
Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.
Indexed holds 1 funding round and 3 investors for this company. The full record is or through the API.
About
Lexent Bio developed novel liquid biopsy technology to diagnose and treat cancer. Acquired by Foundation Medicine in June 2020.
Summary
Lexent Bio is a Biotech company based in San Francisco, United States, founded in 2009. It has raised $10.2M in total across 1 round. Investors include Charge Ventures, Correlation Ventures and iFly.vc.
Tech & App Stack
4 technologies & apps tracked
Every product and vendor across these categories, with where each signal came from.
Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.
Funding History
Investors
Similar Companies
Altos Labs combines academic science and industry development to create medicines that restore ce...
BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...
BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...
AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/lexent-bio"><img src="https://indexed.vc/api/badge/company/lexent-bio" alt="Lexent Bio on Indexed.vc" width="260" height="76" /></a>